Product Change-Priority Mail Express and Priority Mail Negotiated Service Agreement, 26589 [2015-11067]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 89 / Friday, May 8, 2015 / Notices
I. Introduction
In accordance with 39 U.S.C. 3642
and 39 CFR 3020.30 et seq., the Postal
Service filed a formal request and
associated supporting information to
add Priority Mail Express & Priority
Mail Contract 18 to the competitive
product list.1
The Postal Service
contemporaneously filed a redacted
contract related to the proposed new
product under 39 U.S.C. 3632(b)(3) and
39 CFR 3015.5. Id. Attachment B.
To support its Request, the Postal
Service filed a copy of the contract, a
copy of the Governors’ Decision
authorizing the product, proposed
changes to the Mail Classification
Schedule, a Statement of Supporting
Justification, a certification of
compliance with 39 U.S.C. 3633(a), and
an application for non-public treatment
of certain materials. It also filed
supporting financial workpapers.
asabaliauskas on DSK5VPTVN1PROD with NOTICES
II. Notice of Commission Action
The Commission establishes Docket
Nos. MC2015–49 and CP2015–61 to
consider the Request pertaining to the
proposed Priority Mail Express &
Priority Mail Contract 18 product and
the related contract, respectively.
The Commission invites comments on
whether the Postal Service’s filings in
the captioned dockets are consistent
with the policies of 39 U.S.C. 3632,
3633, or 3642, 39 CFR part 3015, and 39
CFR part 3020, subpart B. Comments are
due no later than May 11, 2015. The
public portions of these filings can be
accessed via the Commission’s Web site
(https://www.prc.gov).
The Commission appoints Kenneth R.
Moeller to serve as Public
Representative in these dockets.
III. Ordering Paragraphs
It is ordered:
1. The Commission establishes Docket
Nos. MC2015–49 and CP2015–61 to
consider the matters raised in each
docket.
2. Pursuant to 39 U.S.C. 505, Kenneth
R. Moeller is appointed to serve as an
officer of the Commission to represent
the interests of the general public in
these proceedings (Public
Representative).
3. Comments are due no later than
May 11, 2015.
4. The Secretary shall arrange for
publication of this order in the Federal
Register.
1 Request of the United States Postal Service to
Add Priority Mail Express & Priority Mail Contract
18 to Competitive Product List and Notice of Filing
(Under Seal) of Unredacted Governors’ Decision,
Contract, and Supporting Data, May 1, 2015
(Request).
VerDate Sep<11>2014
16:38 May 07, 2015
Jkt 235001
By the Commission.
Shoshana M. Grove,
Secretary.
[FR Doc. 2015–11079 Filed 5–7–15; 8:45 am]
BILLING CODE 7710–FW–P
POSTAL SERVICE
Product Change—Priority Mail Express
and Priority Mail Negotiated Service
Agreement
Postal ServiceTM.
Notice.
AGENCY:
ACTION:
The Postal Service gives
notice of filing a request with the Postal
Regulatory Commission to add a
domestic shipping services contract to
the list of Negotiated Service
Agreements in the Mail Classification
Schedule’s Competitive Products List.
DATES: Effective date: May 8, 2015.
FOR FURTHER INFORMATION CONTACT:
Elizabeth A. Reed, 202–268–3179.
SUPPLEMENTARY INFORMATION: The
United States Postal Service® hereby
gives notice that, pursuant to 39 U.S.C.
3642 and 3632(b)(3), on May 1, 2015, it
filed with the Postal Regulatory
Commission a Request of the United
States Postal Service to Add Priority
Mail Express & Priority Mail Contract 18
to Competitive Product List. Documents
are available at www.prc.gov, Docket
Nos. MC2015–49, CP2015–61.
SUMMARY:
Stanley F. Mires,
Attorney, Federal Requirements.
[FR Doc. 2015–11067 Filed 5–7–15; 8:45 am]
BILLING CODE 7710–12–P
REAGAN-UDALL FOUNDATION FOR
THE FOOD AND DRUG
ADMINISTRATION
[BAC 416404]
Request for Scientific Advisory
Committee Nominations
Request for nominations to the
Scientific Advisory Committee for the
Foundation’s Innovation in Medical
Evidence Development and Surveillance
(IMEDS) program.
ACTION:
The Reagan-Udall Foundation
for the Food and Drug Administration
(FDA), which was created by Title VI of
the Food and Drug Amendments of
2007, is requesting nominations for its
Innovation in Medical Evidence
Development and Surveillance (IMEDS)
Scientific Advisory Committee. The
IMEDS Scientific Advisory Committee
will provide scientific oversight and
SUMMARY:
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
26589
guidance of the IMEDS Program, and
will report to the Reagan-Udall
Foundation for the FDA’s Board of
Directors. Instructions on submitting
nominations are listed in the
‘‘Background’’ section.
DATES: All nominations must be
submitted to the Reagan-Udall
Foundation for the FDA by May 24,
2015. IMEDS Scientific Advisory
Committee members will be selected by
the IMEDS Steering Committee before
July 15, 2015; those selected will be
notified by July 30, 2015 regarding the
Steering Committee’s decision.
Location: The Reagan-Udall
Foundation for the FDA is located at
1025 Connecticut Ave. NW., Suite 1000,
Washington, DC 20036.
FOR FURTHER INFORMATION CONTACT:
Nicole Spear, Reagan-Udall Foundation
for the FDA, 202–828–1210.
Nominations should be sent to IMEDS@
ReaganUdall.org. Email subject line:
SAC Nomination.
SUPPLEMENTARY INFORMATION:
I. Background
The Reagan-Udall Foundation for the
FDA (the Foundation) is an independent
501(c)(3) not-for-profit, organization
created by Congress to advance the
mission of FDA to modernize medical,
veterinary, food, food ingredient, and
cosmetic product development;
accelerate innovation, and enhance
product safety. With the ultimate goal of
improving public health, the
Foundation provides a unique
opportunity for different sectors (FDA,
patient groups, academia, other
government entities, and industry) to
work together in a transparent way to
create exciting new research projects to
advance regulatory science.
The Foundation acts as a neutral third
party to establish novel, scientific
collaborations. Much like any other
independently developed information,
FDA evaluates the scientific information
from these collaborations to determine
how Reagan-Udall Foundation projects
can help the agency to fulfill its
mission.
The Innovation in Medical Evidence
Development and Surveillance (IMEDS)
program is offered by the Foundation.
IMEDS is a public-private partnership
created to build upon the significant
progress made on research methodology
by the Sentinel Initiative and the
Observational Medical Outcomes
Partnership (OMOP).
IMEDS’s primary objective is to
advance the science and tools necessary
to support post-market evidence
generation on regulated products,
including safety surveillance and
E:\FR\FM\08MYN1.SGM
08MYN1
]]>Agencies
[Federal Register Volume 80, Number 89 (Friday, May 8, 2015)]
[Notices]
[Page 26589]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-11067]
=======================================================================
-----------------------------------------------------------------------
POSTAL SERVICE
Product Change--Priority Mail Express and Priority Mail
Negotiated Service Agreement
AGENCY: Postal ServiceTM.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Postal Service gives notice of filing a request with the
Postal Regulatory Commission to add a domestic shipping services
contract to the list of Negotiated Service Agreements in the Mail
Classification Schedule's Competitive Products List.
DATES: Effective date: May 8, 2015.
FOR FURTHER INFORMATION CONTACT: Elizabeth A. Reed, 202-268-3179.
SUPPLEMENTARY INFORMATION: The United States Postal Service[supreg]
hereby gives notice that, pursuant to 39 U.S.C. 3642 and 3632(b)(3), on
May 1, 2015, it filed with the Postal Regulatory Commission a Request
of the United States Postal Service to Add Priority Mail Express &
Priority Mail Contract 18 to Competitive Product List. Documents are
available at www.prc.gov, Docket Nos. MC2015-49, CP2015-61.
Stanley F. Mires,
Attorney, Federal Requirements.
[FR Doc. 2015-11067 Filed 5-7-15; 8:45 am]
BILLING CODE 7710-12-P
